Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
    • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
May 05, 2025May 06, 2025Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$21.05$37,280-1.36%
Feb 11, 2025Feb 13, 2025Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$24.33$137,276-4.32%
Feb 03, 2025Feb 05, 2025Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$20.12$103,940-4.04%
Jan 22, 2025Jan 24, 2025Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$18.94$30,002-1.47%
Sep 09, 2024Sep 10, 2024Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$11.52$25,240-1.99%
Feb 01, 2024Feb 02, 2024Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$8.53$35,789-4.05%
Jan 23, 2024Jan 25, 2024Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$9.07$14,138-1.94%
Oct 03, 2023Oct 04, 2023Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$8.25$25,504-3.71%
Feb 01, 2023Feb 03, 2023Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$21.75$38,697-2.12%
Jan 24, 2023Jan 26, 2023Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$21.9$33,952-2.38%
Oct 04, 2022Oct 07, 2022Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$25.68$78,119-4.46%
Jan 31, 2022Feb 02, 2022Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$27.4$30,825-1.64%
Jan 24, 2022Jan 26, 2022Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$24.98$46,838-3.10%
Oct 04, 2021Oct 05, 2021Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$24.77$75,746-4.81%
Aug 17, 2021Aug 17, 2021Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$17.12$24,086-2.17%
Feb 05, 2021Feb 09, 2021Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$31.5$70,864-3.65%
Feb 02, 2021Feb 04, 2021Heerma Peter
Chief Commercial Officer
SellTravere Therapeutics, Inc.TVTX$29.83$33,589-1.93%
Oct 02, 2020Oct 06, 2020Heerma Peter
Chief Commercial Officer
SellRetrophin, Inc.RTRX$19.13$83,691-9.37%